2026 Update in Hematology and Medical Oncology

The 2026 Update in Hematology and Medical Oncology and 14th Annual Board Review is a four-day comprehensive course offering an in-depth, current review of the diagnosis, staging, and management of neoplastic diseases across both solid tumors and hematologic malignancies. Expert-led lectures cover a wide spectrum of disease-specific topics, including gastrointestinal, gynecologic, thoracic, head and neck, genitourinary, soft tissue and skin, and central nervous system oncology, in addition to hematologic oncology.

This course is designed for medical oncology professionals—including physicians, nurses, pharmacists, advanced practice providers, fellows, and residents—seeking a comprehensive update in the field as well as those preparing for American Board of Internal Medicine (ABIM) certification and recertification examinations in Hematology and Medical Oncology.

The program will take place live over four days via Zoom. Each session will conclude with interactive Q&A with faculty. Participants will also receive access to an online syllabus after the course that includes recorded videos of the presentations as well as downloadable PDF versions of the faculty slide decks.

A detailed agenda, including topics and faculty, will be released soon.

1. Define state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers and hematologic cancers
2. Discuss recent treatment advances in solid tumor and hematologic oncology and apply knowledge gained in modern clinical practice
3. Prepare for ABIM examinations in medical oncology and hematology

This program will be held virtually via Zoom. Detailed access instructions will be provided prior to the start of the program.

Registration Fees

• Physicians (MDs, PhDs, DOs): $2,000

• Advanced Practice Providers, Residents, Fellows, Nurses, & Other Healthcare Providers: $1,075

• Industry Professionals: $3,500*

• MSK Employees: Complimentary

*An “industry professional” is defined as any individual, irrespective of their provider type (such as MDs, PhDs, APPs, RNs, etc.) that is employed by an ineligible company. Please review our Registration Policy for Industry Professionals for more information.

Registration Discounts: Discounted registration is available for specific groups. If eligible, you will receive further instructions and a promotion code to use during registration. View our policy on Registration Discounts for more information.

Cancellation Policy: For details on our cancellation terms, please review our Cancellation Policy.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This activity is approved for AMA PRA Category 1 Credits™ and ABIM MOC points.

MSK Course Directors

David H. Ilson, MD, PhD
Attending, Member, Gastrointestinal Oncology Service
Professor of Medicine, Weill Cornell Medical College

Paul A. Hamlin, MD
Attending, Lymphoma Service
Professor of Clinical Medicine, Weill Cornell Medical College

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.